Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sabrina E. Calderon
Observed name:
Sabrina Calderon
Institutions:
Henry Ford Health,
University of California, Irvine
Observed institutions:
Henry Ford Health,
University of California, Irvine
OpenAlex ID:
A5111643219
Homologous Repair‐Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy
2025
·
Alica K. Beutel
, Christopher J. Halbrook
, et al.
·
United European Gastroenterology Journal
·
4
Increased AID results in mutations at the CRLF2 locus implicated in Latin American ALL health disparities
2024
·
Valeria Rangel
, Jason N. Sterrenberg
, et al.
·
Nature Communications
·
3
PDF
Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis
2026
·
Rima Singh
, Natalie Yousefian
, et al.
·
Cellular and Molecular Gastroenterology and Hepatology
·
1
Abstract LB053: Targeting macrophage metabolism in pancreatic cancer
2025
·
Austin D. Silva
, Sabrina E. Calderon
, et al.
·
Cancer Research
·
1
Abstract A016: Defining UHRF1 as a crucial factor in pancreatic cancer progression and treatment
2025
·
Austin D. Silva
, Sabrina E. Calderon
, et al.
·
Cancer Research
Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer
2025
·
Alica K. Beutel
, Sabrina Calderon
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract C052: Repurposing Statins to Target Gemcitabine Resistance in Pancreatic Cancer
2024
·
Sabrina Calderon
, Alica K. Beutel
, et al.
·
Cancer Research
Abstract A056: Targeting the mevalonate biosynthesis pathway in gemcitabine resistant pancreatic cancer
2024
·
Alica K. Beutel
, Sabrina Calderon
, et al.
·
Cancer Research
Show more works
View as search
Works count:
8
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type
